Polymer Capital Management (HK)’s Legend Biotech LEGN Stock Holding History

Polymer Capital Management (HK)’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.77M	Buy	+165,209	New	+$4.46M	0.24%	54
2025 Q4	–	Sell	-162,420	Closed	-$5.3M	–	207
2025 Q3	$5.3M	Buy	162,420 +365	+0.2%	+$13.5K	0.73%	42
2025 Q2	$5.75M	Buy	162,055 +125,068	+338%	+$4.05M	0.87%	35
2025 Q1	$1.25M	Buy	36,987 +8,260	+29%	+$296K	0.21%	76
2024 Q4	$935K	Sell	28,727 -13,100	-31%	-$543K	0.16%	119
2024 Q3	$2.04M	Buy	41,827 +11,827	+39%	+$630K	0.47%	62
2024 Q2	$1.33M	Buy	+30,000	New	+$1.38M	0.27%	79
2024 Q1	–	Sell	-5,000	Closed	-$301K	–	215
2023 Q4	$301K	Buy	+5,000	New	+$317K	0.1%	105

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Polymer Capital Management (HK)'s LEGN Position: Q2 2026 in Review

Polymer Capital Management (HK) opened a new position in Legend Biotech (LEGN) in Q2 2026: 165,209 shares worth $4.77M. The stake represents 0.24% of the portfolio and ranks #54 among its holdings. This is a return to the name: Polymer Capital Management (HK) previously reported a position in LEGN as recently as Q3 2025.

Polymer Capital Management (HK) first reported a position in LEGN in Q4 2023 and has held it in 8 quarters since. The position peaked at $5.75M in Q2 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Polymer Capital Management (HK) held 165,209 shares of Legend Biotech worth $4.77M as of Q2 2026.
Legend Biotech was a new Polymer Capital Management (HK) position in Q2 2026.
Legend Biotech made up 0.24% of Polymer Capital Management (HK)'s portfolio in Q2 2026, its #54 holding.
Polymer Capital Management (HK) first reported a position in Legend Biotech in Q4 2023 and has held it in 8 quarters since.
Polymer Capital Management (HK)'s Legend Biotech position peaked at $5.75M in Q2 2025.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Polymer Capital Management (HK)'s 13F filing for Q2 2026, filed 13 Aug 2026.